Comparison of risk assessment tools for cardiovascular diseases: results of an Iranian cohort study

Several popular cardiovascular risk assessment tools have been developed in Western countries; however, the predictive abilities of these tools have not been evaluated in Middle Eastern countries. The present study aimed to determine the abilities of cardiovascular risk assessment tools in a populat...

Full description

Saved in:
Bibliographic Details
Published in:Public health (London) 2021-11, Vol.200, p.116-123
Main Authors: Motamed, N., Ajdarkosh, H., Perumal, D., Ashrafi, G.H., Maadi, M., Safarnezhad Tameshkel, F., Farahani, B., Rezaie, N., Nikkhah, M., Faraji, A.H., Miri, S.M., Roozafzai, F., khoonsari, M., Karbalaie Niya, M.H., Zamani, F.
Format: Article
Language:English
Subjects:
Ability
American College of Cardiology/American Heart Association (ACC/AHA) prediction tool
Cardiology
Cardiovascular disease
Cardiovascular diseases
Cohort analysis
Confidence intervals
Framingham general cardiovascular risk profile
Health risks
Heart diseases
High risk
Population studies
Predictions
Primary care
Risk assessment
Risk assessment tools
Systematic Coronary Risk Evaluation (SCORE)
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Several popular cardiovascular risk assessment tools have been developed in Western countries; however, the predictive abilities of these tools have not been evaluated in Middle Eastern countries. The present study aimed to determine the abilities of cardiovascular risk assessment tools in a population-based study in Northern Iran. Population-based cohort study in Northern Iran. In total, 2883 individuals (1629 men and 1254 women), aged 40–74 years, were included in the study. We determined the predictive abilities of the American College of Cardiology/American Heart Association (ACC/AHA) risk prediction tool, the Framingham general cardiovascular risk profile in primary care settings, and the Systematic Coronary Risk Evaluation (SCORE) equations for low- and high-risk European countries. Receiver operating characteristic (ROC) analysis was used to determine the predictive abilities of these four risk assessment tools. Based on areas under curve (AUC) values and related 95% confidence intervals (95% CIs), the discriminative abilities of the ACC/AHA tool, the Framingham approach, and the SCORE for low- and high-risk European countries to estimate non-fatal cardiovascular disease (CVD) events were 0.6625, 0.6517, 0.6476 and 0.6458, respectively, in men, and 0.7722, 0.7525, 0.7330 and 0.7331, respectively, in women. Moreover, the abilities of these four tools to estimate fatal CVD events were found to be 0.8614, 0.8329, 0.7996 and 0.7988 in men, and 0.8779, 0.8372, 0.8535 and 0.8518 in women, respectively. The cardiovascular risk assessment tools investigated in this study showed acceptable predictive abilities in women. The ACC/AHA approach showed slightly better performance compared with the SCORE tool; however, the SCORE tool benefited from the lowest cost compared with all the other tools.
ISSN:0033-3506
1476-5616
DOI:10.1016/j.puhe.2021.09.021